The Defiant·

Isomorphic Labs Raises $5 Billion for AI Drug Design

Your call?

Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.

Share

More news